Volume 90 Issue 24
Issue Date: June 11, 2012
p. 17 ConcentratesIssue Date: June 11, 2012
Partners Aim To Make Oncology Biosimilars
Department: Business
Keywords: biosimilars, generic drugs, pharmaceuticals, oncology, monoclonal antibodies
Keywords: biosimilars, generic drugs, pharmaceuticals, oncology, monoclonal antibodies
Dr. Reddy’s Laboratories, in India, and Merck Serono, a division of Germany’s Merck KGaA, will jointly develop generic biologic, or biosimilar, drugs. They will focus primarily on developing, manufacturing, and selling monoclonal antibodies for oncology purposes. The partners will share R&D costs and divide up worldwide commercial activities. Dr. Reddy’s will handle early product development, including Phase I clinical trials. After that, Merck Serono will assume manufacturing and development through Phase III.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society
Leave A Comment